Muscle 3243A→G mutation load and capacity of the mitochondrial energy-generating system

Annals of Neurology

Volumn 63, Issue 4, 2008, Pages 473-481

  Janssen, Antoon J M ^a   Schuelke, Markus ^b   Smeitink, Jan A M ^a   Trijbels, Frans J M ^a   Sengers, Rob C A ^a   Lucke, Barbara ^b   Wintjes, Liesbeth T M ^a   Morava, Eva ^a   Van Engelen, Baziel G M ^a   Smits, Bart W ^a   Hol, Frans A ^a   Siers, Marloes H ^a   Ter Laak, Henk ^a   Van Der Knaap, Marjo S ^c   Van Spronsen, Francjan J ^d   Rodenburg, Richard J T ^a   Van Den Heuvel, Lambert P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENE TRANSFER; HUMAN; MALE; MELAS SYNDROME; MITOCHONDRIAL ENERGY TRANSFER; MUSCLE MITOCHONDRION; MUSCLE TISSUE; PRIORITY JOURNAL; RESPIRATORY CHAIN; RNA TRANSPORT; COMPARATIVE STUDY; ELECTRON TRANSPORT; ENERGY METABOLISM; GENETICS; INFANT; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SKELETAL MUSCLE;

ADENOSINE; GUANINE; MITOCHONDRIAL DNA;

ADENOSINE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; ENERGY METABOLISM; FEMALE; GUANINE; HUMANS; INFANT; MALE; MELAS SYNDROME; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUTATION;

EID: 42949170382     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21328     Document Type: Article

References (45)

1. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488.
2. Kobayashi M, Morishita H, Sugiyama N, et al. Two cases of NADH-coenzyme Q reductase deficiency: relationship to MELAS syndrome. J Pediatr 1987;110:223-227.
3. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.
4. Leu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990;173:816-822.
5. MITOMAP. A human mitochondrial genome database. Available at: http://www.miromap.org. Accessed Jan 9, 2008.
6. Lev D, Nissenkorn A, Leshinsky-Silver E, et al. Clinical presentations of mitochondrial cardiomyopathies. Pediatr Cardiol 2004;25:443-450.
7. leu(UUR) gene. Diabetes 1994;43:746-751.
8. Chang TM, Chi CS, Tsai CR, et al. Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol 2004;31:374-377.
9. Durand-Dubief F, Ryvlin P, Mauguiere F. Polymorphism of epilepsy associated with the 3243A>G mutation of mitochondrial DNA (MELAS): reasons for delayed diagnosis. Rev Neurol 2004;160:824-829.
10. Pons RP, Andreu AL, Checcarelli N, et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 2004;144:81-85.
11. Jones M, Mitchell P, Wang JJ, Sue C. MELAS 3243A>G mitochondrial DNA mutation and age related maculopathy. Am J Ophthalmol 2004;138:1051-1053.
12. Finsterer J, Stollberger C, Wanschitz J, et al. Nail-patella syndrome associated with respiratory chain disorder. Eur Neurol 2001;46:92-95.
13. Munakata K, Iwamoto K, Bundo M, Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatr 2005;57:525-532.
14. Kornblum C, Broicher R, Walther E, et al. Sensorineural hearing loss in patients with chronic progressive external ophthalmoplegia or Kearns-Sayre syndrome. J Neurol 2005;252:1101-1107.
15. Sangkhathat S, Kusafuka T, Yoneda A, et al. Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation. Pediatr Surg Int 2005;21:745-748.
16. Leu(UUK) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant 2005;20:336-341.
17. Liang MH, Wong LJ. Yield of mtDNA mutation analysis in 2,000 patients. Am J Med Genet 1998;77:395-400.
18. Leu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem 2000;275:19198-19209.
19. Leu(UUR) decreases the efficiency of aminoacylation. Biochemistry 2003;42:958-964.
20. Vielhaber S, Varlamov DA, Kudina TA, et al. Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients harbouring the 3243A>G point mutation or large scale deletions of mitochondrial DNA. J Neuropathol Exp Neurol 2002;61:885-895.
21. Bentlage HACM, de Coo R, ter Laak HJ, et al. Human diseases with defects in oxidative phosphorylation. 1. Decreased amounts of assembled oxidative phosphorylation complexes in mitochondrial encephalomyopathies. Eur J Biochem 1995;227:909-915.
22. Wong LC, Liang MH, Kwon H, et al. A cystic fibrosis patient with two novel mutations in the mitochondrial DNA: mild disease led to delayed diagnosis both disorders. Am J Med Genet 2002;113:59-64.
23. Chinnery PF, Taylor DJ, Manners D, et al. No correlation between muscle 3243A>G mutation load and mitochondrial function in vivo. Neurology 2001;56:1101-1104.
24. Leu(UUR) gene. Muscle Nerve 1995;3:S119-S123.
25. Attardi G, Yoneda M, Chomyn A. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1995;1271:241-248.
26. Janssen AJM, Trijbels JMF, Sengers RCA, et al. Determination of the mitochondrial energy generating capacity in human muscle mitochondria: diagnostic procedure and application to human pathology. Clin Chem 2006;52:860-871.
27. Fischer JC, Ruirenbeek W, Trijbels JMF, et al. Estimation of NADH oxidation in human skeletal muscle mitochondria. Clin Chim Acta 1986;155:263-273.
28. Bentlage HACM, Wendel U, Schägger H, et al. Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology 1996;47:243-248.
29. Cooperstein S, Lazarow A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem 1951;189:665-670.
30. Srere PA. Citrate synthase, EC 4.1.3.7. citrate oxaloacetate lyase (CoA-acetylating). Methods Enzymol 1969;13:3-11.
31. Schuelke M. An economic method for the fluorescent labeling of PCR fragments. Nat Biotechnol 2000;18:233-234.
32. Detjen AK, Tinschert S, Kaufmann D, et al. Analysis of mitochondrial DNA in discordant monozygotic twins with neurofibromatosis type 1. Twin Res Hum Genet 2007;10:486-495.
33. Taylor RW, Taylor GA, Durham SE, Turnbull DM. The determination of complete human mitochondrial DNA sequences in single cells: implication for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res 2001;29:e74.
34. Leu(UUR) mutation. Neuropediatrics 2001;32:183-190.
35. Ingman M, Gyllensten U. mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res 2006;34:749-751.
36. Crimi M, Del Bo R, Galbiati S, et al. Mitochondrial A12308G polymorphism affects clinical features in patients with single mtDNA macrodeletion. Eur J Hum Genet 2003;11:896-898.
37. Deschauer M, Chinnery PF, Schaefer AM, et al. No association of the mitochondrial DNA A12308G polymorphism with increased risk of stroke in patients with the 3243A>G mutation. J Neurol Neurosurg Psychiatr 2004;75:1200-1207.
38. Sue CM, Quigley A, Katsabanis S, et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci 1998;161:36-39.
39. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550.
40. Mariotti C, Savarese N, Suomalainen A, et al. Genotype to phenotype correlations in mirochondrial encephalomyopathies associated with the 3243A>G mutation of mitochondrial DNA. J Neurol 1995;242:304-312.
41. Chomyn A. Mitochondrial genetic control of assembly and function of complex I in mammalian cells. J Bioenerg Biomembr 2001;33:251-257.
42. Ugalde C, Triepels RH, Coenen MJH, et al. Impaired complex I assembly in a Leigh syndrome patient with a novel missense mutation in the ND6 gene. Ann Neurol 2003;54:665-669.
43. Kirino Y, Goto Y, Campos Y, et al. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc Natl Acad Sci USA 2005;102:7127-7132.
44. Wittig I, Carrozzo R, Santorelli FM, Schägger H. Super-complexes and subcomplexes of mitochondrial oxidative phosphorylation. Biochim Biophys Acta 2006;1757:1066-1072.
45. Luft R, Ikkos D, Palmieri G, et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962;41:1776-1804.